Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 133 Pages
Report ld: 6549015
Request Sample
Customized Report
The global Ephedrine API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ephedrine API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Ephedrine API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ephedrine API. The Ephedrine API market size, estimates, and forecasts are provided in terms of output/shipments (Kiloton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ephedrine API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ephedrine API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Ephedrine API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Ephedrine API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Ephedrine API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Ephedrine API Market Overview
1.1 Product Definition
1.2 Ephedrine API by Type
1.2.1 Global Ephedrine API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity 99%
1.2.3 Purity Above 99%
1.3 Ephedrine API by Application
1.3.1 Global Ephedrine API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Research Organization
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ephedrine API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Ephedrine API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Ephedrine API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Ephedrine API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ephedrine API Production Market Share by Manufacturers (2021–2026)
2.2 Global Ephedrine API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Ephedrine API, Industry Ranking, 2024 vs 2025
2.4 Global Ephedrine API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Ephedrine API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Ephedrine API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Ephedrine API, Product Offerings and Applications
2.8 Global Key Manufacturers of Ephedrine API, Date of Entry into the Industry
2.9 Ephedrine API Market Competitive Situation and Trends
2.9.1 Ephedrine API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Ephedrine API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Ephedrine API Production by Region
3.1 Global Ephedrine API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Ephedrine API Production Value by Region (2021–2032)
3.2.1 Global Ephedrine API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Ephedrine API by Region (2027–2032)
3.3 Global Ephedrine API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Ephedrine API Production Volume by Region (2021–2032)
3.4.1 Global Ephedrine API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Ephedrine API by Region (2027–2032)
3.5 Global Ephedrine API Market Price Analysis by Region (2021–2032)
3.6 Global Ephedrine API Production, Value, and Year-over-Year Growth
3.6.1 North America Ephedrine API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Ephedrine API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Ephedrine API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Ephedrine API Production Value Estimates and Forecasts (2021–2032)
4 Ephedrine API Consumption by Region
4.1 Global Ephedrine API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Ephedrine API Consumption by Region (2021–2032)
4.2.1 Global Ephedrine API Consumption by Region (2021–2026)
4.2.2 Global Ephedrine API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Ephedrine API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Ephedrine API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ephedrine API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Ephedrine API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ephedrine API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Ephedrine API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ephedrine API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Ephedrine API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Ephedrine API Production by Type (2021–2032)
5.1.1 Global Ephedrine API Production by Type (2021–2026)
5.1.2 Global Ephedrine API Production by Type (2027–2032)
5.1.3 Global Ephedrine API Production Market Share by Type (2021–2032)
5.2 Global Ephedrine API Production Value by Type (2021–2032)
5.2.1 Global Ephedrine API Production Value by Type (2021–2026)
5.2.2 Global Ephedrine API Production Value by Type (2027–2032)
5.2.3 Global Ephedrine API Production Value Market Share by Type (2021–2032)
5.3 Global Ephedrine API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Ephedrine API Production by Application (2021–2032)
6.1.1 Global Ephedrine API Production by Application (2021–2026)
6.1.2 Global Ephedrine API Production by Application (2027–2032)
6.1.3 Global Ephedrine API Production Market Share by Application (2021–2032)
6.2 Global Ephedrine API Production Value by Application (2021–2032)
6.2.1 Global Ephedrine API Production Value by Application (2021–2026)
6.2.2 Global Ephedrine API Production Value by Application (2027–2032)
6.2.3 Global Ephedrine API Production Value Market Share by Application (2021–2032)
6.3 Global Ephedrine API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Malladi Drugs & Pharmaceuticals
7.1.1 Malladi Drugs & Pharmaceuticals Ephedrine API Company Information
7.1.2 Malladi Drugs & Pharmaceuticals Ephedrine API Product Portfolio
7.1.3 Malladi Drugs & Pharmaceuticals Ephedrine API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Malladi Drugs & Pharmaceuticals Main Business and Markets Served
7.1.5 Malladi Drugs & Pharmaceuticals Recent Developments/Updates
7.2 Cheng Fong Chemical
7.2.1 Cheng Fong Chemical Ephedrine API Company Information
7.2.2 Cheng Fong Chemical Ephedrine API Product Portfolio
7.2.3 Cheng Fong Chemical Ephedrine API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Cheng Fong Chemical Main Business and Markets Served
7.2.5 Cheng Fong Chemical Recent Developments/Updates
7.3 Siegfried Group
7.3.1 Siegfried Group Ephedrine API Company Information
7.3.2 Siegfried Group Ephedrine API Product Portfolio
7.3.3 Siegfried Group Ephedrine API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Siegfried Group Main Business and Markets Served
7.3.5 Siegfried Group Recent Developments/Updates
7.4 Embio
7.4.1 Embio Ephedrine API Company Information
7.4.2 Embio Ephedrine API Product Portfolio
7.4.3 Embio Ephedrine API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Embio Main Business and Markets Served
7.4.5 Embio Recent Developments/Updates
7.5 Chifeng Arker Pharmaceutical
7.5.1 Chifeng Arker Pharmaceutical Ephedrine API Company Information
7.5.2 Chifeng Arker Pharmaceutical Ephedrine API Product Portfolio
7.5.3 Chifeng Arker Pharmaceutical Ephedrine API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Chifeng Arker Pharmaceutical Main Business and Markets Served
7.5.5 Chifeng Arker Pharmaceutical Recent Developments/Updates
7.6 JSN Chemicals
7.6.1 JSN Chemicals Ephedrine API Company Information
7.6.2 JSN Chemicals Ephedrine API Product Portfolio
7.6.3 JSN Chemicals Ephedrine API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 JSN Chemicals Main Business and Markets Served
7.6.5 JSN Chemicals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ephedrine API Industry Chain Analysis
8.2 Ephedrine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ephedrine API Production Modes and Processes
8.4 Ephedrine API Sales and Marketing
8.4.1 Ephedrine API Sales Channels
8.4.2 Ephedrine API Distributors
8.5 Ephedrine API Customer Analysis
9 Ephedrine API Market Dynamics
9.1 Ephedrine API Industry Trends
9.2 Ephedrine API Market Drivers
9.3 Ephedrine API Market Challenges
9.4 Ephedrine API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ephedrine API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 130
USD 3950.00
(Single User License)
The global Ephedrine API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 136
USD 4900.00
(Single User License)
The global market for Ephedrine API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 101
USD 3950.00
(Single User License)
The global market for Ephedrine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 94
USD 2900.00
(Single User License)
The global Ephedrine API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 76
USD 4250.00
(Single User License)
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Published Date: 2024-02-19
Pages: 94
USD 3950.00
(Single User License)
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Published Date: 2024-01-11
Pages: 86
USD 2900.00
(Single User License)
The global market for Ephedrine API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 130
The global Ephedrine API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 136
The global market for Ephedrine API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 101
The global market for Ephedrine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 94
The global Ephedrine API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 76
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Published: 2024-04-07
Pages: 90
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Published: 2024-02-19
Pages: 94
Ephedrine API is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Published: 2024-01-11
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now